FDBusiness.com

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease

 Breaking News
  • Arla Foods UK Launches New Standards Model to Bring Sustainable Change to Dairy Farming With ongoing volatility in the global milk markets, increasing consumer misunderstanding of the sector, polarised levels of support for UK dairy farmers and a new post-Brexit Agriculture Bill the challenges for dairy farmers are mounting. Farmer-owned co-operative Arla Foods has launched ‘Arla UK 360’ – a new standard in UK dairy farming. The Arla UK 360 [...]...
  • €172 Million to Promote EU Agri-food Products In and Outside the EU The European Commission will provide funding of €172.5 million from the EU agricultural budget to promote EU agri-food products in Europe and across the world. 79 campaigns, covering a wide range of products such as dairy products, olives and olive oil, and fruit and vegetables, will be rolled out over the next three years. Agriculture and [...]...
  • €40 Million VistaMilk SFI Research Centre Launched in Ireland The Irish Government has launched the new VistaMilk SFI Research Centre which is jointly funded by Science Foundation Ireland (SFI) and the Department of Agriculture, Food and the Marine. The VistaMilk Centre will be hosted by Teagasc Moorepark, in partnership with a number of research performing organisations. Multinational and SME companies in the food and ICT [...]...
  • Autumn Chill Puts Sunday Lunch Back on the Menu For UK Shoppers UK shoppers have returned to seasonal favourites as supermarket spending cools off, according to the latest figures from Kantar Worldpanel, for the 12 weeks to 7 October 2018. Overall sales grew 3.2% compared to the same 12 weeks last year. Though this is a slight slowdown from the highs reached during 2018’s hot summer, sales [...]...
  • Müller Milk & Ingredients Completes Integration and Appoints CFO Brian Watson has been appointed as Chief Finance Officer at Müller Milk & Ingredients (MMI). He joins the business from Marmon, a $7.7 billion Berkshire Hathaway company operating in the supermarket and food service sector. The appointment comes as MMI confirms completion of the biggest integration the UK dairy industry has ever seen – merging [...]...

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease

Nestlé Institute of Health Sciences to Develop New Test For Early Alzheimer’s Disease
September 28
10:15 2015

The Nestlé Institute of Health Sciences SA (NIHS), a fundamental research institute of the global nutrition, health and wellness company Nestlé, has signed a research collaboration agreement with AC Immune SA – a leading Lausanne-based biopharmaceutical company focused on neurodegenerative diseases. The aim of the collaboration is to develop a sensitive, minimally invasive Tau diagnostic assay for early Alzheimer’s disease (AD) by applying Nestlé’s proprietary multiplexed ultrasensitive antibody technology platform.

Tangles of Tau proteins are recognised as one of two major hallmarks of neurodegeneration, the other being beta-amyloid (Abeta) plaques. Tangles and other abnormal forms of Tau protein accumulate inside the brain cells and spread between cells of people with Alzheimer’s disease over a long period of time. It is now well established that Tau correlates well with cognitive decline and disease progression. Furthermore, Tau may develop into a suitable biomarker for early diagnosis of the disease.

“This collaboration agreement opens up exciting new possibilities in the quest to better understand and combat this debilitating disease,” comments Ed Baetge, Head of NIHS. “By bringing together our ultrasensitive next-generation diagnostic platform and AC Immune’s expertise in the field, we hope to develop a minimally invasive Tau diagnostic using patients’ blood which can identify Alzheimer’s patients at a very early, and potentially pre-symptomatic, stage of the disease.”

Andrea Pfeifer, CEO of AC Immune, comments: “The development of a minimally invasive diagnostic test to identify patients at very early stages is considered as one of the most pressing needs in the treatment of Alzheimer’s disease.”

Ed Baetge adds: “Our overarching goal at NIHS is to develop nutritional approaches and technologies that help people maintain or improve their cognitive vigour especially for early diagnosis and targeted intervention to combat this global health problem.”

Nestlé’s technology is a patented diagnostic antibody-based platform capable of measuring soluble proteins with high sensitivity and specificity. The technology was developed by Prometheus Laboratories In., a Nestlé Health Science company. Since 2013, NIHS has applied it in Brain Health research, specifically in Alzheimer’s. The assay uses a triplex antibody microarray-based platform that measures the expression and activation of target proteins in tissues, blood or other fluids.

About Author

mike

mike

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • October 18, 2018Future Food-Tech London - Marketing Partnership
  • October 21, 2018Int'l Food Products Exhibition (Sial)
  • October 25, 2018Italian Espresso Coffee Show (TriestEspresso Expo)
  • October 25, 2018Finnish Food Fair
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements